Loading…
Loading…
EQUITY / NASDAQ · XNCM
eXoZymes Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗5.83 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 5.83 USD · Volume 2,037
21 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -2,953,890 USD | -2,548,045 USD | — |
| Net income | -2,878,614 USD | -2,360,286 USD | — |
| Cash and cash equivalents | 5,652,696 USD | — | — |
| Total liabilities | 4,328,255 USD | — | — |
| Total equity | 3,654,100 USD | 7,235,705 USD | -49.50% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 5,652,696 USD | — | — | 3,039,343 USD | 3,039,343 USD | 5,098,687 USD | — | — |
| Net incomeIncome statement | -2,878,614 USD | -5,248,861 USD | -2,370,247 USD | — | -9,158,734 USD | -2,286,991 USD | -6,503,698 USD | -2,360,286 USD |
| Operating profitIncome statement | -2,953,890 USD | -5,340,864 USD | — | — | -9,716,471 USD | -2,522,208 USD | -7,020,981 USD | -2,548,045 USD |
| Total assetsBalance sheet | 7,982,355 USD | — | — | 5,971,517 USD | 5,971,517 USD | 7,719,049 USD | — | — |
| Total equityBalance sheet | 3,654,100 USD | — | 1,528,100 USD | 3,397,249 USD | 3,397,249 USD | 5,374,422 USD | — | 7,235,705 USD |
| Total liabilitiesBalance sheet | 4,328,255 USD | — | — | 2,574,268 USD | 2,574,268 USD | 2,344,627 USD | — | — |
| Capital expendituresCash flow statement | — | 57,603 USD | — | — | 169,917 USD | — | 94,929 USD | — |
| Financing cash flowCash flow statement | — | 5,835,675 USD | — | — | -27,709 USD | — | -17,155 USD | — |
| Investing cash flowCash flow statement | — | -57,603 USD | — | — | -150,218 USD | — | -75,228 USD | — |
| Operating cash flowCash flow statement | — | -3,164,719 USD | — | — | -6,502,040 USD | — | -4,528,240 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/30/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.